MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
BBNX — Beta Bionics, Inc. Common Stock
NasdaqBeta Bionics, Inc. Common Stock
$18.96
+0.09(+0.48%)
- O
- 18.87
- H
- 19.26
- L
- 18.27
- V
- 514.77K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About BBNX
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
SectorNot available
IPO DateJan 30, 2025
Employees423
Stock ExchangeNasdaq
Ticker SymbolBBNX
Websitehttps://www.betabionics.com
Key Financial Statistics
| Market Cap | $1.16B |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $8.80 - $32.71 |
| 52-Week Avg Volume | 1.08M |
| VWAP | $18.85 |
| Transactions | 10,270 |
| Total Recorded Bars | 421 days |